| Name | (3S,5R,8R,9S,10R,13R,14S,17R)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde |
|---|---|
| Synonyms |
Cannogenin thevetoside
Peruvosid 3-((6-deoxy-3-o-methyl-alpha-l-glucopyranosyl)oxy)-14-hydroxy-19-oxo-cd-20 cannogeninalpha-l-thevetoside Peruvoside Enordin Cd-20(22)-enolide,3-[(6-deoxy-3-O-methyl-a-L-glucopyranosyl)oxy]-14-hydroxy-19-oxo-, (3b,5b) Cd-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-α-L-glucopyranosyl)oxy]-14-hydroxy-19-oxo-, (3β,5β) 3β-[(6-Deoxy-3-O-methyl-α-L-glucopyranosyl)oxy]-14-hydroxy-19-oxo-5β,14β-cd-20-enolide Encordin (3-beta,5-beta)-oxy-19-oxo EINECS 214-659-9 cd-20(22)-enolide,3-((6-deoxy-3-o-methyl-alpha-l-glucopyranosyl)oxy)-14-hydr MFCD00133752 peruvosid (3β,5β)-3-(6-Deoxy-3-O-methyl-α-L-glucopyranosyl]oxyl)-14-hydroxy-19-oxocd-20-enolide Peruvoside from Thevetia neriifolia Cannogenin α-L-thevetoside Pervoside (3S,5R,8R,9S,10R,13R,14S,17R)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-10-cbaldehyde [3BETA,5BETA]-3-[6-DEOXY-3-O-METHYL-ALPHA-L-GLUCOPYRANOSYL)OXYL]-14-HYDROXY-19-OXOCD-20-ENOLIDE PERUVOSIDE(RG) CANNOGENNIN-ALPHA-L-THEVETOSIDE (3β,5β)-3-[(6-Deoxy-3-O-Methyl-α-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocd-20-enolide PERUVOSIDE //BP encordin PERUVOSIDE FROM THEVETIA NERIIFOLIA (3beta,5beta)-3-[(6-deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocd-20-enolide cannogeninthevetoside (22)-enolide Cannogenin |A-L-Thevetoside |
| Description | Peruvoside is a potent inhibitor of Src, PI3K, JNK, STAT, and EGFR. Peruvoside induces apoptosis and autophagy and possesses a broad spectrum of anticancer activity in breast, lung, liver cancers and leukemia. Peruvoside is a broad-spectrum and potent antiviral activity against positive-sense RNA viruses. Peruvoside sensitizes Gefitinib (HY-50895)-resistant tumour cells (A549, PC9/gef and H1975) to Gefitinib[1][2][3][4]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.31g/cm3 |
|---|---|
| Boiling Point | 731.6ºC at 760 mmHg |
| Melting Point | 161-164ºC |
| Molecular Formula | C30H44O9 |
| Molecular Weight | 548.66 |
| Flash Point | 236.2ºC |
| Exact Mass | 548.29900 |
| PSA | 131.75000 |
| LogP | 2.28920 |
| Vapour Pressure | 1.04E-24mmHg at 25°C |
| Index of Refraction | 1.588 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | T |
|---|---|
| Risk Phrases | 23/24/25 |
| Safety Phrases | 36/37/39-45 |
| WGK Germany | 3 |
| RTECS | FH4915000 |